Symptom Management for Irritable Bowel Syndrome

NYU Langone Health1 site in 1 country183 target enrollmentNovember 2012

ConditionsIrritable Bowel Syndrome

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Irritable Bowel Syndrome
Sponsor: NYU Langone Health
Enrollment: 183
Locations: 1
Primary Endpoint: Symptom severity-abdominal pain
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to test the efficacy of a symptom management treatment strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with Irritable Bowel Syndrome (IBS) in adults.

Registry

clinicaltrials.gov

Start Date

November 2012

End Date

November 1, 2019

Last Updated

5 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

NYU Langone Health

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Men and women 18 to 70 years of age.
•Diagnosis of IBS based on ROME III criteria.
•Complete symptom diaries and return completed diaries at all sessions.

Exclusion Criteria

•History of co-existing gastrointestinal, and/or gynecological, and/or urologic pathology.
•Alarm symptoms according to ROME III.
•Individuals currently receiving other types of complementary therapies.
•Individuals with an acute medical condition requiring acute medical attention.